{"status":"ok","message-type":"work","message-version":"1.0.0","message":{"indexed":{"date-parts":[[2026,9,9]],"date-time":"2026-09-09T15:42:26Z","timestamp":1788968546841,"version":"build-2803163510"},"reference-count":22,"publisher":"Scientific Scholar","content-domain":{"domain":["ijmr.org.in"],"crossmark-restriction":true},"short-container-title":["Indian J Med Res"],"abstract":"<jats:sec>\n<jats:title>Background &amp; objectives<\/jats:title>\n<jats:p>Despite advancements in antiretroviral therapy, drug-resistant strains of HIV (human immunodeficiency virus) remain a global health concern. Natural compounds from medicinal plants offer a promising avenue for developing new HIV-1 PR (protease) inhibitors. This study aimed to explore the potential of compounds derived from <jats:italic>Calotropis procera<\/jats:italic>, a medicinal plant, as inhibitors of HIV-1 PR.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Methods<\/jats:title>\n<jats:p>This <jats:italic>in silico<\/jats:italic> study utilized natural compound information and the crystal structure of HIV-1 PR. Molecular docking of 17 steroidal cardenolides from <jats:italic>Calotropis procera<\/jats:italic> against HIV-1 PR was performed using AutoDock 4.2 to identify compounds with higher antiviral potential. A dynamic simulation study was performed to provide insights into the stability, binding dynamics, and potential efficacy of the top potential antiviral compound as an HIV-1 therapeutic.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Results<\/jats:title>\n<jats:p>We found that all tested cardenolides had higher binding affinities than Amprenavir, indicating their potential as potent HIV-1 PR inhibitors. Voruscharin and uscharidin displayed the strongest interactions, forming hydrogen bonds and hydrophobic interactions with HIV-1 PR. Voruscharin showed improved stability with lower RMSD (Root Mean Square Deviation) values and reduced fluctuations in binding site residues but increased flexibility in certain regions. The radius of gyration analysis confirmed a stable binding pose between HIV-1 PR and Voruscharin.<\/jats:p>\n<\/jats:sec>\n<jats:sec>\n<jats:title>Interpretation &amp; conclusions<\/jats:title>\n<jats:p>These findings suggest that <jats:italic>Calotropis procera<\/jats:italic> could potentially be a source of compounds for developing novel HIV-1 PR inhibitors, contributing to the efforts to combat HIV. Further studies and clinical trials are needed to evaluate the safety and efficacy of these compounds as potential drug candidates for the treatment of HIV-1 infection.<\/jats:p>\n<\/jats:sec>","DOI":"10.25259\/ijmr_2115_23","type":"journal-article","created":{"date-parts":[[2024,10,1]],"date-time":"2024-10-01T09:20:14Z","timestamp":1727774414000},"page":"78-86","update-policy":"https:\/\/doi.org\/10.25259\/crossmark_policy","source":"Crossref","is-referenced-by-count":9,"title":["Identification of steroidal cardenolides from <i>Calotropis procera<\/i> as novel HIV-1 PR inhibitors: A molecular docking &amp; molecular dynamics simulation study"],"prefix":"10.25259","volume":"160","author":[{"given":"Kandagatla","family":"Swapna","sequence":"first","affiliation":[{"name":"Department of Zoology, Kakatiya University, Hanamkonda, Warangal, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"M.","family":"Srujana","sequence":"additional","affiliation":[{"name":"Department of Pharmacy, Chaitanya (Deemed to be University), Kishanpura, Hanamkonda, Warangal, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]},{"given":"Estari","family":"Mamidala","sequence":"additional","affiliation":[{"name":"Department of Zoology, Kakatiya University, Hanamkonda, Warangal, Telangana, India"}],"role":[{"vocabulary":"crossref","role":"author"}]}],"member":"10894","published-online":{"date-parts":[[2024,9,30]]},"reference":[{"key":"10.25259\/IJMR_2115_23\/ref-2","first-page":"532","article-title":"Current status of antiretroviral therapy","volume":"7","author":"Bhattacharjee","year":"2019","journal-title":"Clin Epidemiol Glob Health"},{"key":"10.25259\/IJMR_2115_23\/ref-3","first-page":"532","article-title":"Natural products as HIV-1 protease inhibitors: A review","volume":"35","author":"Shah","year":"2021","journal-title":"Phytother Res"},{"key":"10.25259\/IJMR_2115_23\/ref-4","first-page":"357","article-title":"Antiviral activity of calotropis procera against HIV and herpes simplex virus","volume":"52","author":"Gupta","year":"2020","journal-title":"Indian J Pharmacol"},{"key":"10.25259\/IJMR_2115_23\/ref-5","first-page":"1","article-title":"Identification of potential natural compounds as HIV-1 protease inhibitors using molecular docking and simulation studies","author":"Alqahtani","year":"2021","journal-title":"J Biomol Str Dyn"},{"key":"10.25259\/IJMR_2115_23\/ref-6","first-page":"101290","article-title":"Antiviral activity of 3-O-methylfunicone isolated from aspergillus fumigatus against HIV-1","volume":"33","author":"Salem","year":"2021","journal-title":"J King Saud Univ Sci"},{"key":"10.25259\/IJMR_2115_23\/ref-7","first-page":"2927","article-title":"Herbal medicine: An effective therapeutic approach for the management and prevention of HIV\/AIDS","volume":"25","author":"Rizvi","year":"2019","journal-title":"Curr Pharm Des"},{"key":"10.25259\/IJMR_2115_23\/ref-8","first-page":"299","article-title":"HIV-1 protease inhibitors: A review of molecular selectivity and toxicity","volume":"12","author":"Mittal","year":"2020","journal-title":"HIV AIDS (Auckl)"},{"key":"10.25259\/IJMR_2115_23\/ref-9","doi-asserted-by":"crossref","first-page":"464","DOI":"10.1093\/nar\/gky1004","article-title":"RCSB protein data bank: Biological macromolecular structures enabling research and education in fundamental biology, biomedicine, biotechnology and energy","volume":"47","author":"Burley","year":"2018","journal-title":"Nucleic Acids Res"},{"key":"10.25259\/IJMR_2115_23\/ref-10","doi-asserted-by":"publisher","first-page":"2785","DOI":"10.1002\/jcc.21256","article-title":"AutoDock4 and autodocktools4: Automated docking with selective receptor flexibility","volume":"30","author":"Morris","year":"2009","journal-title":"J Comput Chem"},{"key":"10.25259\/IJMR_2115_23\/ref-11","doi-asserted-by":"publisher","first-page":"131066","DOI":"10.1016\/j.molstruc.2021.131066","article-title":"Pharmacophore screening, molecular docking, ADMET prediction and MD simulations for identification of ALK and MEK potential dual inhibitors","volume":"1245","author":"Zhang","year":"2021","journal-title":"J Mol Struct"},{"key":"10.25259\/IJMR_2115_23\/ref-12","doi-asserted-by":"publisher","first-page":"522","DOI":"10.1016\/j.matpr.2021.05.595","article-title":"Phenolic compounds as promising drug candidates against COVID-19-an integrated molecular docking and dynamics simulation study","volume":"51","author":"Davella","year":"2022","journal-title":"Mater Today Proc"},{"key":"10.25259\/IJMR_2115_23\/ref-13","doi-asserted-by":"publisher","first-page":"1047","DOI":"10.1016\/S0006-3495(97)78756-3","article-title":"The statistical-thermodynamic basis for computation of binding affinities: A critical review","volume":"72","author":"Gilson","year":"1997","journal-title":"Biophys J"},{"key":"10.25259\/IJMR_2115_23\/ref-14","doi-asserted-by":"publisher","first-page":"1454","DOI":"10.1016\/j.jiph.2021.07.012","article-title":"Rilpivirine inhibits SARS-CoV-2 protein targets: A potential multi-target drug","volume":"14","author":"Ameen","year":"2021","journal-title":"J Infect Public Health"},{"key":"10.25259\/IJMR_2115_23\/ref-15","doi-asserted-by":"publisher","first-page":"1071","DOI":"10.1152\/ajpgi.00182.2006","article-title":"HIV protease inhibitors activate the unfolded protein response and disrupt lipid metabolism in primary hepatocytes","volume":"291","author":"Zhou","year":"2006","journal-title":"Am J Physiol Gastrointest Liver Physiol"},{"key":"10.25259\/IJMR_2115_23\/ref-16","doi-asserted-by":"crossref","first-page":"891","DOI":"10.1039\/C3MB70537D","article-title":"Molecular docking and molecular dynamics studies on \u03b2-lactamases and penicillin binding proteins","volume":"10","author":"Kumar","year":"2014","journal-title":"Mol Biosyst"},{"key":"10.25259\/IJMR_2115_23\/ref-17","doi-asserted-by":"crossref","first-page":"3699","DOI":"10.1111\/j.1742-4658.2010.07771.x","article-title":"Amprenavir complexes with HIV-1 protease and its drug-resistant mutants altering hydrophobic clusters","volume":"277","author":"Shen","year":"2010","journal-title":"FEBS J"},{"key":"10.25259\/IJMR_2115_23\/ref-18","doi-asserted-by":"publisher","first-page":"211","DOI":"10.1016\/s0169-409x(99)00027-7","article-title":"Oral absorption of the HIV protease inhibitors: A current update","volume":"39","author":"Williams","year":"1999","journal-title":"Adv Drug Deliv Rev"},{"key":"10.25259\/IJMR_2115_23\/ref-19","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.jtbi.2008.07.030","article-title":"Molecular dynamic simulations analysis of ritronavir and lopinavir as SARS-CoV 3CLpro inhibitors","volume":"254","author":"Nukoolkarn","year":"2008","journal-title":"J Theor Biol"},{"key":"10.25259\/IJMR_2115_23\/ref-20","doi-asserted-by":"publisher","first-page":"861","DOI":"10.1016\/j.bpj.2009.11.011","article-title":"Determination of ensemble-average pairwise root mean-square deviation from experimental B-factors","volume":"98","author":"Kuzmanic","year":"2010","journal-title":"Biophys J"},{"key":"10.25259\/IJMR_2115_23\/ref-21","doi-asserted-by":"publisher","first-page":"840","DOI":"10.1016\/j.sjbs.2021.10.023","article-title":"In silico prediction of mozenavir as a potential drug for SARS-CoV-2 infection via binding multiple drug targets","volume":"29","author":"Mamidala","year":"2022","journal-title":"Saudi J Biol Sci"},{"key":"10.25259\/IJMR_2115_23\/ref-22","doi-asserted-by":"publisher","first-page":"2607","DOI":"10.1080\/07391102.2020.1751298","article-title":"Identification of chymotrypsin-like protease inhibitors of SARS-CoV-2 via integrated computational approach","volume":"39","author":"Khan","year":"2021","journal-title":"J Biomol Struct Dyn"},{"key":"10.25259\/IJMR_2115_23\/ref-23","doi-asserted-by":"crossref","first-page":"102","DOI":"10.1016\/j.jmb.2008.05.062","article-title":"Effect of flap mutations on structure of HIV-1 protease and inhibition by saquinavir and darunavir","volume":"381","author":"Liu","year":"2018","journal-title":"J Mol Biol"}],"container-title":["The Indian Journal of Medical Research"],"original-title":[],"language":"en","link":[{"URL":"http:\/\/ijmr.org.in\/identification-of-steroidal-cardenolides-from-calotropis-procera-as-novel-hiv-1-pr-inhibitors-a-molecular-docking-molecular-dynamics-simulation-study\/","content-type":"text\/html","content-version":"vor","intended-application":"text-mining"},{"URL":"http:\/\/ijmr.org.in\/identification-of-steroidal-cardenolides-from-calotropis-procera-as-novel-hiv-1-pr-inhibitors-a-molecular-docking-molecular-dynamics-simulation-study\/","content-type":"unspecified","content-version":"vor","intended-application":"similarity-checking"}],"deposited":{"date-parts":[[2024,12,20]],"date-time":"2024-12-20T03:30:02Z","timestamp":1734665402000},"score":1,"resource":{"primary":{"URL":"http:\/\/ijmr.org.in\/identification-of-steroidal-cardenolides-from-calotropis-procera-as-novel-hiv-1-pr-inhibitors-a-molecular-docking-molecular-dynamics-simulation-study\/"}},"subtitle":[],"short-title":[],"issued":{"date-parts":[[2024,9,30]]},"references-count":22,"alternative-id":["10.25259\/IJMR_2115_23"],"URL":"https:\/\/doi.org\/10.25259\/ijmr_2115_23","relation":{},"ISSN":["0971-5916"],"issn-type":[{"value":"0971-5916","type":"print"}],"subject":[],"published":{"date-parts":[[2024,9,30]]},"article-number":"78"}}